Is home blood pressure variability itself an interventional target beyond lowering mean home blood pressure during anti-hypertensive treatment

Satoshi Hoshide, Yuichiro Yano, motohiro shimizu, Kazuo Eguchi, Joji Ishikawa, Kazuomi Kario

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

It is unknown whether home blood pressure (BP) variability reduction is associated with target organ damage (TOD) protection independently of home mean BP reduction. We enrolled 310 hypertensive patients whose systolic BP (SBP) at home was over 135mmHg. The subjects measured their BP in the morning and evening for 7 days. In addition, we measured urinary albumin excretion (UAE) as a marker of TOD before and after 6 months of candesartan treatment (+thiazidediuretics). At baseline, UAE was associated with average home SBP (r=0.24, P<0.001), the s.d. of home SBP (r=0.15, P=0.011), and the maximum home SBP (r=0.27, P<0.001). During the intervention, significant reductions were found in average home SBP (146±13 vs. 132±12mmHg, P<0.001), s.d. of home SBP (12.9±4.8 vs. 11.8±4.4mmHg, P<0.001), and maximum home SBP (172.5±18.0 vs. 155.9±17.5mmHg, P<0.001). UAE levels were significantly reduced after 6months of therapy compared with baseline (18.9 vs. 12.1 mgg-1 Cre, P<0.001). In multiple regression analysis, the treatment-induced reduction in UAE was significantly associated with that of average home BP (P=0.003) but was not associated with that of s.d. of home SBP or that of maximum home SBP. Home BP variability is not itself an interventional target beyond lowering mean home BP during anti-hypertensive treatment.

Original languageEnglish
Pages (from-to)862-866
Number of pages5
JournalHypertension Research
Volume35
Issue number8
DOIs
Publication statusPublished - Aug 1 2012

Fingerprint

Antihypertensive Agents
Blood Pressure
Albumins
Therapeutics
Regression Analysis

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Is home blood pressure variability itself an interventional target beyond lowering mean home blood pressure during anti-hypertensive treatment. / Hoshide, Satoshi; Yano, Yuichiro; shimizu, motohiro; Eguchi, Kazuo; Ishikawa, Joji; Kario, Kazuomi.

In: Hypertension Research, Vol. 35, No. 8, 01.08.2012, p. 862-866.

Research output: Contribution to journalArticle

Hoshide, Satoshi ; Yano, Yuichiro ; shimizu, motohiro ; Eguchi, Kazuo ; Ishikawa, Joji ; Kario, Kazuomi. / Is home blood pressure variability itself an interventional target beyond lowering mean home blood pressure during anti-hypertensive treatment. In: Hypertension Research. 2012 ; Vol. 35, No. 8. pp. 862-866.
@article{f6e86cdf9eb5492b8de4142eb98b6e08,
title = "Is home blood pressure variability itself an interventional target beyond lowering mean home blood pressure during anti-hypertensive treatment",
abstract = "It is unknown whether home blood pressure (BP) variability reduction is associated with target organ damage (TOD) protection independently of home mean BP reduction. We enrolled 310 hypertensive patients whose systolic BP (SBP) at home was over 135mmHg. The subjects measured their BP in the morning and evening for 7 days. In addition, we measured urinary albumin excretion (UAE) as a marker of TOD before and after 6 months of candesartan treatment (+thiazidediuretics). At baseline, UAE was associated with average home SBP (r=0.24, P<0.001), the s.d. of home SBP (r=0.15, P=0.011), and the maximum home SBP (r=0.27, P<0.001). During the intervention, significant reductions were found in average home SBP (146±13 vs. 132±12mmHg, P<0.001), s.d. of home SBP (12.9±4.8 vs. 11.8±4.4mmHg, P<0.001), and maximum home SBP (172.5±18.0 vs. 155.9±17.5mmHg, P<0.001). UAE levels were significantly reduced after 6months of therapy compared with baseline (18.9 vs. 12.1 mgg-1 Cre, P<0.001). In multiple regression analysis, the treatment-induced reduction in UAE was significantly associated with that of average home BP (P=0.003) but was not associated with that of s.d. of home SBP or that of maximum home SBP. Home BP variability is not itself an interventional target beyond lowering mean home BP during anti-hypertensive treatment.",
author = "Satoshi Hoshide and Yuichiro Yano and motohiro shimizu and Kazuo Eguchi and Joji Ishikawa and Kazuomi Kario",
year = "2012",
month = "8",
day = "1",
doi = "10.1038/hr.2012.46",
language = "English",
volume = "35",
pages = "862--866",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Is home blood pressure variability itself an interventional target beyond lowering mean home blood pressure during anti-hypertensive treatment

AU - Hoshide, Satoshi

AU - Yano, Yuichiro

AU - shimizu, motohiro

AU - Eguchi, Kazuo

AU - Ishikawa, Joji

AU - Kario, Kazuomi

PY - 2012/8/1

Y1 - 2012/8/1

N2 - It is unknown whether home blood pressure (BP) variability reduction is associated with target organ damage (TOD) protection independently of home mean BP reduction. We enrolled 310 hypertensive patients whose systolic BP (SBP) at home was over 135mmHg. The subjects measured their BP in the morning and evening for 7 days. In addition, we measured urinary albumin excretion (UAE) as a marker of TOD before and after 6 months of candesartan treatment (+thiazidediuretics). At baseline, UAE was associated with average home SBP (r=0.24, P<0.001), the s.d. of home SBP (r=0.15, P=0.011), and the maximum home SBP (r=0.27, P<0.001). During the intervention, significant reductions were found in average home SBP (146±13 vs. 132±12mmHg, P<0.001), s.d. of home SBP (12.9±4.8 vs. 11.8±4.4mmHg, P<0.001), and maximum home SBP (172.5±18.0 vs. 155.9±17.5mmHg, P<0.001). UAE levels were significantly reduced after 6months of therapy compared with baseline (18.9 vs. 12.1 mgg-1 Cre, P<0.001). In multiple regression analysis, the treatment-induced reduction in UAE was significantly associated with that of average home BP (P=0.003) but was not associated with that of s.d. of home SBP or that of maximum home SBP. Home BP variability is not itself an interventional target beyond lowering mean home BP during anti-hypertensive treatment.

AB - It is unknown whether home blood pressure (BP) variability reduction is associated with target organ damage (TOD) protection independently of home mean BP reduction. We enrolled 310 hypertensive patients whose systolic BP (SBP) at home was over 135mmHg. The subjects measured their BP in the morning and evening for 7 days. In addition, we measured urinary albumin excretion (UAE) as a marker of TOD before and after 6 months of candesartan treatment (+thiazidediuretics). At baseline, UAE was associated with average home SBP (r=0.24, P<0.001), the s.d. of home SBP (r=0.15, P=0.011), and the maximum home SBP (r=0.27, P<0.001). During the intervention, significant reductions were found in average home SBP (146±13 vs. 132±12mmHg, P<0.001), s.d. of home SBP (12.9±4.8 vs. 11.8±4.4mmHg, P<0.001), and maximum home SBP (172.5±18.0 vs. 155.9±17.5mmHg, P<0.001). UAE levels were significantly reduced after 6months of therapy compared with baseline (18.9 vs. 12.1 mgg-1 Cre, P<0.001). In multiple regression analysis, the treatment-induced reduction in UAE was significantly associated with that of average home BP (P=0.003) but was not associated with that of s.d. of home SBP or that of maximum home SBP. Home BP variability is not itself an interventional target beyond lowering mean home BP during anti-hypertensive treatment.

UR - http://www.scopus.com/inward/record.url?scp=84864656838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864656838&partnerID=8YFLogxK

U2 - 10.1038/hr.2012.46

DO - 10.1038/hr.2012.46

M3 - Article

VL - 35

SP - 862

EP - 866

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 8

ER -